Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Paul Glezen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Physiology

Procedures

Geographic Areas

Texas

Phenomena

Disease Outbreaks

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
20
Piedra, Pedro
10
Taber, Larry
9
Englund, Janet
8
Gaglani, Manjusha
7
Couch, Robert
6
Atmar, Robert
6
Fewlass, Charles
6
Herschler, Gayla
5
Kozinetz, Claudia
5
Munoz, Flor
5
Greenberg, Stephen
4
Longini, Ira
4
Halloran, Elizabeth
3
Gruber, William
3
Keitel, Wendy

Sign-in to see all Coauthors

Publications

TOP 3
Glezen W Paul
Benefits of a universal influenza immunization program: more than the reduction in the use of antibiotics.
Glezen W Paul
Respiratory syncytial virus: back to basics.
Glezen W Paul
Universal influenza vaccination and live attenuated influenza vaccination of children.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Paul Glezen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Glezen W Paul
Benefits of a universal influenza immunization program: more than the reduction in the use of antibiotics.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(5):757-8.
2009: Glezen W Paul
Respiratory syncytial virus: back to basics.
The Journal of allergy and clinical immunology 2009;123(2):404-5.
2008: Glezen W Paul
Universal influenza vaccination and live attenuated influenza vaccination of children.
The Pediatric infectious disease journal 2008;27(10 Suppl):S104-9.
2008: Glezen William Paul
Modifying clinical practices to manage influenza in children effectively.
The Pediatric infectious disease journal 2008;27(8):738-43.
2008: Gaglani Manjusha J; Piedra Pedro A; Riggs Mark; Herschler Gayla; Fewlass Charles; Glezen W Paul
Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.
The Pediatric infectious disease journal 2008;27(5):444-52.
2007: Piedra Pedro A; Gaglani Manjusha J; Kozinetz Claudia A; Herschler Gayla B; Fewlass Charles; Harvey Dianne; Zimmerman Nadine; Glezen W Paul
Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
Pediatrics 2007;120(3):e553-64.
2007: Halloran M Elizabeth; Piedra Pedro A; Longini Ira M; Gaglani Manjusha J; Schmotzer Brian; Fewlass Charles; Herschler Gayla B; Glezen W Paul
Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
Vaccine 2007;25(20):4038-45.
2007: Hite Ladonna K; Glezen W Paul; Demmler Gail J; Munoz Flor M
Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2007;11(1):40-7.
2006: Glezen W Paul
Asthma, influenza, and vaccination.
The Journal of allergy and clinical immunology 2006;118(6):1199-206; quiz 1207-8.
2006: Glezen W Paul
Herd protection against influenza.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;37(4):237-43.
2006: Glezen W Paul
Influenza control.
The New England journal of medicine 2006;355(1):79-81.
2006: Glezen W Paul; Simonsen Lone
Commentary: benefits of influenza vaccine in US elderly--new studies raise questions.
International journal of epidemiology 2006;35(2):352-3.
2006: Glezen W Paul
A response to strategy #2: streamlining the regulatory process.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42 Suppl 3():S141-4.
2005: Piedra Pedro A; Gaglani Manjusha J; Riggs Mark; Herschler Gayla; Fewlass Charles; Watts Matt; Kozinetz Claudia; Hessel Colin; Glezen W Paul
Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
Pediatrics 2005;116(3):e397-407.
2005: Washington Michael L; Humiston Sharon G; Fauerbach Peter B; Glezen W Paul; Black Steve; Shinefield Henry; Pulley Jill
A personnel time-motion study of intranasal influenza vaccination in healthy children.
Vaccine 2005;23(40):4879-85.
2005: Beckham J David; Cadena Ana; Lin Jiejian; Piedra Pedro A; Glezen W Paul; Greenberg Stephen B; Atmar Robert L
Respiratory viral infections in patients with chronic, obstructive pulmonary disease.
The Journal of infection 2005;50(4):322-30.
2005: Munoz Flor M; Greisinger Anthony J; Wehmanen Oscar A; Mouzoon Melanie E; Hoyle James C; Smith Frances A; Glezen W Paul
Safety of influenza vaccination during pregnancy.
American journal of obstetrics and gynecology 2005;192(4):1098-106.
2005: Piedra Pedro A; Gaglani Manjusha J; Kozinetz Claudia A; Herschler Gayla; Riggs Mark; Griffith Melissa; Fewlass Charles; Watts Matt; Hessel Colin; Cordova Julie; Glezen W Paul
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.
Vaccine 2005;23(13):1540-8.
2004: Glezen W Paul
The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures.
The Pediatric infectious disease journal 2004;23(11 Suppl):S202-6.
2004: Glezen W Paul
New vaccines for old diseases: trivalent cold-adapted influenza vaccine.
Pediatric annals 2004;33(8):545-50.
2004: Glezen W Paul; Piedra Pedro A; Longini Ira M; Halloran M Elizabeth
Safety of cold-adapted live influenza vaccine.
The Pediatric infectious disease journal 2004;23(6):593-4; author reply 594.
2004: Glezen W Paul
Cold-adapted, live attenuated influenza vaccine.
Expert review of vaccines 2004;3(2):131-9.
2004: Gaglani Manjusha J; Piedra Pedro A; Herschler Gayla B; Griffith Melissa E; Kozinetz Claudia A; Riggs Mark W; Fewlass Charles; Halloran M Elizabeth; Longini Ira M; Glezen W Paul
Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.
Archives of pediatrics & adolescent medicine 2004;158(1):65-73.
2004: Glezen W Paul
Control of influenza.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2004;31(1):39-41.
2003: Halloran M Elizabeth; Longini Ira M; Gaglani Manjusha J; Piedra Pedro A; Chu Haitao; Herschler Gayla B; Glezen W Paul
Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures.
American journal of epidemiology 2003;158(4):305-11.
2003: Glezen W Paul
Session IV. Ethical, liability and regulatory issues.
Vaccine 2003;21(24):3501-2.
2003: Piedra Pedro A; Jewell Alan M; Cron Stanley G; Atmar Robert L; Glezen W Paul
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.
Vaccine 2003;21(24):3479-82.
2003: Munoz Flor M; Piedra Pedro A; Glezen W Paul
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women.
Vaccine 2003;21(24):3465-7.
2003: Englund Janet A; Glezen W P
Maternal immunization with Haemophilus influenzae type b vaccines in different populations.
Vaccine 2003;21(24):3455-9.
2003: Glezen W Paul
Effect of maternal antibodies on the infant immune response.
Vaccine 2003;21(24):3389-92.
2003: O'Donnell F T; Munoz F M; Atmar R L; Hwang L Y; Demmler G J; Glezen W P
Epidemiology and molecular characterization of co-circulating influenza A/H3N2 virus variants in children: Houston, Texas, 1997-8.
Epidemiology and infection 2003;130(3):521-31.
2003: Glezen W Paul; Couch Robert B
Estimating deaths due to influenza and respiratory syncytial virus.
JAMA : the journal of the American Medical Association 2003;289(19):2500; author reply 2500-2.
2003: Yu Jigui; Briles David E; Englund Janet A; Hollingshead Susan K; Glezen W Paul; Nahm Moon H
Immunogenic protein contaminants in pneumococcal vaccines.
The Journal of infectious diseases 2003;187(6):1019-23.
2003: Munoz Flor M; Glezen W Paul
Why no effect of maternal respiratory syncytial virus-neutralizing antibody?
Pediatrics 2003;111(1):218-20; author reply 218-20.
2002: Belshe Robert B; Couch Robert B; Glezen William P; Treanor John T
Live attenuated intranasal influenza vaccine.
Vaccine 2002;20(29-30):3429-30.
2002: Glezen W Paul
Influenza vaccination for healthy children.
Current opinion in infectious diseases 2002;15(3):283-7.
2002: Glezen W Paul
Influenza virus in pediatric patients. Introduction.
Seminars in pediatric infectious diseases 2002;13(2):69-70.
2002: Smith Catherine B; Cox Nancy J; Subbarao Kanta; Taber Larry H; Glezen W Paul
Molecular epidemiology of influenza A(H3N2) virus reinfections.
The Journal of infectious diseases 2002;185(7):980-5.
2001: Gaglani M; Riggs M; Kamenicky C; Glezen W P
A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease.
The Pediatric infectious disease journal 2001;20(12):1155-60.
2001: Glezen W P
Maternal vaccines.
Primary care 2001;28(4):791-806, vi-vii.
2001: Munoz F M; Englund J A; Cheesman C C; Maccato M L; Pinell P M; Nahm M H; Mason E O; Kozinetz C A; Thompson R A; Glezen W P
Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation.
Vaccine 2001;20(5-6):826-37.
2001: Santosham M; Englund J A; McInnes P; Croll J; Thompson C M; Croll L; Glezen W P; Siber G R
Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.
The Pediatric infectious disease journal 2001;20(10):931-40.
2001: Glezen W P
The new nasal spray influenza vaccine.
The Pediatric infectious disease journal 2001;20(8):731-2.
2001: Mbawuike I N; Wells J; Byrd R; Cron S G; Glezen W P; Piedra P A
HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children.
The Journal of infectious diseases 2001;183(5):687-96.
2000: Englund J A; Glezen W P
Passive immunization for the prevention of otitis media.
Vaccine 2000;19 Suppl 1():S116-21.
2000: Glezen W P
Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections.
Vaccine 2000;19 Suppl 1():S56-8.
2000: El-Sahly H M; Atmar R L; Glezen W P; Greenberg S B
Spectrum of clinical illness in hospitalized patients with "common cold" virus infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(1):96-100.
2000: Glezen W P; Greenberg S B; Atmar R L; Piedra P A; Couch R B
Impact of respiratory virus infections on persons with chronic underlying conditions.
JAMA : the journal of the American Medical Association 2000;283(4):499-505.
1999: Glezen W P; Alpers M
Maternal immunization.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(2):219-24.
1998: Englund J; Glezen W P; Piedra P A
Maternal immunization against viral disease.
Vaccine 1998;16(14-15):1456-63.
1997: Drews A L; Atmar R L; Glezen W P; Baxter B D; Piedra P A; Greenberg S B
Dual respiratory virus infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(6):1421-9.
1997: Englund J A; Glezen W P; Thompson C; Anwaruddin R; Turner C S; Siber G R
Haemophilus influenzae type b-specific antibody in infants after maternal immunization.
The Pediatric infectious disease journal 1997;16(12):1122-30.
1997: Glezen W P; Taber L H; Frank A L; Gruber W C; Piedra P A
Influenza virus infections in infants.
The Pediatric infectious disease journal 1997;16(11):1065-8.
1996: Suara R O; Piedra P A; Glezen W P; Adegbola R A; Weber M; Mulholland E K; Greenwood B M; Whittle H
Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States.
Clinical and diagnostic laboratory immunology 1996;3(4):477-9.
1996: Mulholland K; Suara R O; Siber G; Roberton D; Jaffar S; N'Jie J; Baden L; Thompson C; Anwaruddin R; Dinan L; Glezen W P; Francis N; Fritzell B; Greenwood B M
Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.
JAMA : the journal of the American Medical Association 1996;275(15):1182-8.
1996: Glezen W P
Emerging infections: pandemic influenza.
Epidemiologic reviews 1996;18(1):64-76.
1995: Piedra P A; Glezen W P; Kasel J A; Welliver R C; Jewel A M; Rayford Y; Hogerman D A; Hildreth S W; Paradiso P R
Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection.
Vaccine 1995;13(12):1095-101.
1995: Englund J A; Glezen W P; Turner C; Harvey J; Thompson C; Siber G R
Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines.
The Journal of infectious diseases 1995;171(1):99-105.
1993: Englund J A; Mbawuike I N; Hammill H; Holleman M C; Baxter B D; Glezen W P
Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants.
The Journal of infectious diseases 1993;168(3):647-56.
1993: Glezen W P
Indications for amantadine in otherwise healthy children.
The Pediatric infectious disease journal 1993;12(1):106.
1993: Piedra P A; Glezen W P; Mbawuike I; Gruber W C; Baxter B D; Boland F J; Byrd R W; Fan L L; Lewis J K; Rhodes L J
Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children.
Vaccine 1993;11(7):718-24.
1992: Englund J A; Glezen W P; Barreto L
Controlled study of a new five-component acellular pertussis vaccine in adults and young children.
The Journal of infectious diseases 1992;166(6):1436-41.
1992: Glezen W P; Englund J A; Siber G R; Six H R; Turner C; Shriver D; Hinkley C M; Falcao O
Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b.
The Journal of infectious diseases 1992;165 Suppl 1():S134-6.
1992: Troendle J F; Demmler G J; Glezen W P; Finegold M; Romano M J
Fatal influenza B virus pneumonia in pediatric patients.
The Pediatric infectious disease journal 1992;11(2):117-21.
1991: Glezen W P; Keitel W A; Taber L H; Piedra P A; Clover R D; Couch R B
Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989.
American journal of epidemiology 1991;133(3):296-304.
1991: Clover R D; Crawford S; Glezen W P; Taber L H; Matson C C; Couch R B
Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses.
The Journal of infectious diseases 1991;163(2):300-4.
1991: Glezen W P; Falcao O; Cate T R; Mintz A A
Nosocomial influenza in a general hospital for indigent patients.
The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prévention des infections / Association pour la prévention des infections a l'hôpital et dans la communaute-Canada ; CHICA-CANADA 1991;6(3):65-7.
1991: Glezen W P
Epidemiological perspective of breastfeeding and acute respiratory illnesses in infants.
Advances in experimental medicine and biology 1991;310():235-40.
1990: Gruber W C; Taber L H; Glezen W P; Clover R D; Abell T D; Demmler R W; Couch R B
Live attenuated and inactivated influenza vaccine in school-age children.
American journal of diseases of children (1960) 1990;144(5):595-600.
1987: Khamapirad T; Glezen W P
Clinical and radiographic assessment of acute lower respiratory tract disease in infants and children.
Seminars in respiratory infections 1987;2(2):130-44.
1987: Kasel J A; Walsh E E; Frank A L; Baxter B D; Taber L H; Glezen W P
Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children.
Viral immunology 1987;1(3):199-205.
1986: Clover R D; Crawford S A; Abell T D; Ramsey C N; Glezen W P; Couch R B
Effectiveness of rimantadine prophylaxis of children within families.
American journal of diseases of children (1960) 1986;140(7):706-9.
1986: Glezen W P; Taber L H; Frank A L; Kasel J A
Risk of primary infection and reinfection with respiratory syncytial virus.
American journal of diseases of children (1960) 1986;140(6):543-6.
1986: Couch R B; Kasel J A; Glezen W P; Cate T R; Six H R; Taber L H; Frank A L; Greenberg S B; Zahradnik J M; Keitel W A
Influenza: its control in persons and populations.
The Journal of infectious diseases 1986;153(3):431-40.
1984: Glezen W P; Frank A L; Taber L H; Kasel J A
Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children.
The Journal of infectious diseases 1984;150(6):851-7.
1984: Kasel J A; Frank A L; Keitel W A; Taber L H; Glezen W P
Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.
Journal of virology 1984;52(3):828-32.
1983: Six H R; Webster R G; Kendal A P; Glezen W P; Griffis C; Couch R B
Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons.
Infection and immunity 1983;42(2):453-8.
1982: Glezen W P; Couch R B; Six H R
The influenza herald wave.
American journal of epidemiology 1982;116(4):589-98.
1980: Puck J M; Glezen W P; Frank A L; Six H R
Protection of infants from infection with influenza A virus by transplacentally acquired antibody.
The Journal of infectious diseases 1980;142(6):844-9.

Sign-in to see more